温馨提示：本站仅提供公开网络链接索引服务，不存储、不篡改任何第三方内容，所有内容版权归原作者所有
AI智能索引来源：http://www.fr.com/insights/webinars/hatch-waxman-2025-year-in-review
点击访问原文链接

Hatch-Waxman 2025 Year in Review

进入原网站 导航首页
Hatch-Waxman 2025 Year in Review Skip to Main Content Why Fish Diversity, Equity & Inclusion Pro Bono & Social Responsibility Legal Operations Pricing Legal Project Management Knowledge Management eDiscovery Legal Technology Services Our People Services Litigation Patent Litigation Trademark, Copyright & Media Litigation Trade Secret Litigation Appellate ITC Litigation & Section 337 Standard Essential Patents Chancery & Corporate Governance Post-Grant Inter Partes Review Post-Grant Review Ex Parte Reexamination Supplemental Examination Patent Patent Prosecution Strategic Patent Counseling & Opinions Patent Portfolio Management Unitary Patent & Unified Patent Court IP Licensing, Transactions & Agreements Trademark & Copyright Counseling & Prosecution Strategic Counseling, Registration & Opinions Advertising & Marketing Domain Names & Internet TTAB Oppositions & Cancellations Digital Millennium Copyright Act Transactions & Agreements Regulatory & Government Affairs Communications & Spectrum Regulation Drug & Medical Device Regulation mHealth & Telemedicine Privacy & Data Security Industries Electrical & Computer Technology Software & Internet Hardware Semiconductors Consumer Electronics Optics Artificial Intelligence Digital Health Digital Media & E-Commerce Financial, Business & FinTech Services Telecommunications Energy & Chemicals Petrochemical Cleantech Life Sciences Biotech & Diagnostics Medical Devices Pharmaceuticals Academic Research & Medical Centers Transportation, Aerospace & Defense Manufacturing Autonomous Vehicles Insights Thought Leadership IP Law Essentials Post-Grant Annual Reports Webinars Podcasts Offices Careers News & Events Contact Us

Webinar January 15, 2026

Hatch-Waxman 2025 Year in Review This Webinar has ended Home Insights Webinars Hatch-Waxman 2025 Year in Review Watch Replay and Access Slides In 2025, the Hatch-Waxman Act remained a cornerstone of the U.S. pharmaceutical industry, shaping the interplay between brand-name manufacturers and generic competitors. Originally designed to balance innovation with access to affordable drugs, this pivotal legislation continued to shape boardroom discussions, regulatory developments, and courtroom disputes.

Whether you are in-house counsel, a pharmaceutical industry leader, or simply curious about how patents affect healthcare, please join Principals Christina Brown-Marshall and Megan Chacon on January 15, 2026, for valuable insights into:

Key trends in the pharmaceutical industry Legal developments affecting branded and generic drugmakers What’s coming up in 2026 If you have any questions, please contact [email protected].

Related Professionals Name Christina D. Brown-Marshall, Ph.D. Title / Practice Area Principal Name Megan A. Chacon Title / Practice Area Principal Related Services Litigation Patent Litigation Regulatory & Government Affairs Drug & Medical Device Regulation Related Industries Life Sciences Pharmaceuticals Upcoming webinars March 11, 2026 A Practical Overview of Damages in Trademark Infringement Cases Read more Related thought leadership Blog February 24, 2026 The Shifting SEP Litigation Landscape: How Changes in the Types of Litigated SEPs Can Affect Implementers Read more Blog February 19, 2026 Be Careful What You Wish For: How Stipulations Become Federal Circuit Issues Read more Article February 13, 2026 Semiconductor Litigation: Advanced Process Transitions and the Next Wave of Patent Risk Read more Blog February 10, 2026 How To Kill a Weak Patent: 10 Strategies After Being Sued Read more Article February 9, 2026 Learning From a Typical Section 1782 Discovery Case Read more Blog February 5, 2026 Federal Circuit Signals Tension in Expert Testimony Jurisprudence: EcoFactor and Barry Read more Article February 4, 2026 Adding to the SEP Toolkit: AI and SEP Analysis Read more Blog January 30, 2026 D. Mass.: “Ensnarement” — a Potent but Often Overlooked Defense to the Doctrine of Equivalents — Need Not Be Raised in the Pleadings Read more Blog January 23, 2026 Protecting Your Edge: Detecting Trade Secret Risks and Preparing for Litigation Read more Blog January 20, 2026 Texas Round-Up: December 2025 Read more Offices Atlanta Austin Boston Chicago Dallas Delaware Houston Minneapolis Munich New York Orange County San Diego Shenzhen Silicon Valley Washington, D.C. Careers Life at Fish Judicial Clerks Law Students Lateral Hires Scientists & Engineers Operations & Admin Staff Training & Benefits FAQ Subscribe Contact Us Site Information Site Map Cookie Policy Disclaimer Privacy Policy Terms of Use

Copyright © 2026 Fish & Richardson P.C.

智能索引记录